By Jaclyn Jaeger2013-12-10T00:00:00
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2015-01-21T12:00:00Z By Joe Mont
The Federal Trade Commission is cracking down on companies with questionable advertising disclosures. The Food and Drug Administration, meanwhile, may allow shorter lists of side effects in drug and medical device ads, even as it prepares tougher standards for how these companies use online advertising and social media. The focus ...
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
2026-01-29T16:39:00Z By Jaclyn Jaeger
Chief compliance officers and general counsel, beware: The Trump administration’s merging of its whole-of-government enforcement approach with its political agenda forewarns of escalating compliance risk on a national scale.
Site powered by Webvision Cloud